The Heavy Metal Poisoning market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Heavy Metal Poisoning: An Overview
Heavy metal poisoning refers to a medical condition when excessive exposure to a heavy metal primarily affects the normal function of the body. Lead, mercury, arsenic, cadmium, and chromium are some of the most common examples of heavy metals that may cause toxicity. Exposure to the heavy metals can occur through diet, drugs, the environment, or during work or play, they can also enter the body via the skin, by inhalation, or ingestion.
The main treatment of heavy metal poisoning is the termination of exposure to the metal. It comprises the use of various chelating agents that cause the toxic (poison) element to bind with the drug and be excreted in the urine.
Heavy Metal Poisoning Market Key Facts
-
In 2016, the National Poisoning Data System (NPDS) of the AAPCC reported 2412 single exposures to lead. Of those exposures, 1188 were in children younger than 6 years, and 671 were in patients older than 19 years.
-
Between 1996 and 2017, there were 1313 deaths in the cohort (including 181 cardiovascular and 33 respiratory) reported in France. Exposure to anthropogenic metals was associated with an increased risk of natural-cause mortality (hazard ratio of 1.16 [1.08–1.24] per interquartile range of exposure), while metals from natural sources were not (Lequy et al, 2019).
-
As per the secondary domain searches, it has been found that there was no gender discrepancy observed in the ratio of male to female.
The increase in market size of Heavy Metal Poisoning is a direct consequence of the rise in the number of cases of Heavy metal poisoning in the 7MM and also the anticipated penetration of upcoming and current therapies.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Heavy Metal Poisoning market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives complete detail of the Heavy Metal Poisoning market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.
Heavy Metal Poisoning Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.
Heavy Metal Poisoning Epidemiology Segmentation
-
Total diagnosed prevalent cases of Heavy Metal Poisoning
-
Total prevalent cases of Heavy Metal Poisoning
-
Prevalent cases of Heavy Metal Poisoning by types of metal
-
Age-specific prevalent cases of Heavy Metal Poisoning
-
Total treated cases of Heavy Metal Poisoning
Heavy Metal Poisoning Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Heavy Metal Poisoning market or expected to get launched during the study period. The analysis covers Heavy Metal Poisoning market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Heavy Metal Poisoning Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Request for Sample PDF Report – https://www.delveinsight.com/sample-request/heavy-metal-poisoning-market
Heavy Metal Poisoning Therapeutics Analysis
The emerging landscape of heavy metal poisoning is not very robust. Not many companies have indulged themselves in developing a novel treatment option for this condition. However, the dynamics of the Heavy Metal Poisoning market are anticipated to change in the coming years.
At present, EmeraMed is involved in the development of a pharmaceutical agent for Heavy Metal Poisoning in the Late-Stage. EmeraMed is investigating their drug candidate Emeramide, also known as NBMI, in ongoing Phase II/III clinical studies.
Apart from this, two of the compounds from Medesis Pharma, NU01 for Plutonium and NU02 targeting Cesium, are in the preclinical phase and they have demonstrated efficacy under the US FDA “Animal Rules”.
Get More Detailed Insights Into the Emerging Therapies & Key Companies – https://www.delveinsight.com/sample-request/heavy-metal-poisoning-market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Heavy Metal Poisoning Competitive Intelligence Analysis
4. Heavy Metal Poisoning Market Overview at a Glance
5. Heavy Metal Poisoning Disease Background and Overview
6. Heavy Metal Poisoning Patient Journey
7. Heavy Metal Poisoning Epidemiology and Patient Population
8. Heavy Metal Poisoning Treatment Algorithm, Current Treatment, and Medical Practices
9. Heavy Metal Poisoning Unmet Needs
10. Key Endpoints of Heavy Metal Poisoning Treatment
11. Heavy Metal Poisoning Marketed Products
12. Heavy Metal Poisoning Emerging Therapies
13. Heavy Metal Poisoning Seven Major Market Analysis
14. Attribute Analysis
15. Heavy Metal Poisoning Market Outlook (7 major markets)
16. Heavy Metal Poisoning Access and Reimbursement Overview
17. KOL Views on the Heavy Metal Poisoning Market.
18. Heavy Metal Poisoning Market Drivers
19. Heavy Metal Poisoning Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report – https://www.delveinsight.com/sample-request/heavy-metal-poisoning-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Other Trending Healthcare Reports by DelveInsight
Brain Hemorrhage Market
“Brain Hemorrhage Market” report delivers an in-depth understanding of the Brain Hemorrhage, historical and forecasted epidemiology as well as the Brain Hemorrhage market trends in 7MM.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/